|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 2
Zeitschriftenartikel
Balanescu, Andra-Rodica 
ORCID: https://orcid.org/0000-0003-0688-9173; Citera, Gustavo ORCID: https://orcid.org/0000-0002-3724-1874; Pascual-Ramos, Virginia ORCID: https://orcid.org/0000-0002-7368-498X; Bhatt, Deepak L. ORCID: https://orcid.org/0000-0002-1278-6245; Connell, Carol A.; Gold, David; Chen, All-Shine; Sawyerr, Gosford; Shapiro, Andrea B.; Pope, Janet E. ORCID: https://orcid.org/0000-0003-1479-5302 und Schulze-Koops, Hendrik ORCID: https://orcid.org/0000-0002-1681-491X
(2022):
Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label, randomised controlled ORAL Surveillance trial.
In: Annals of the Rheumatic Diseases, Bd. 81, Nr. 11: S. 1491-1503
[PDF, 1MB]
ORCID: https://orcid.org/0000-0003-0688-9173; Citera, Gustavo ORCID: https://orcid.org/0000-0002-3724-1874; Pascual-Ramos, Virginia ORCID: https://orcid.org/0000-0002-7368-498X; Bhatt, Deepak L. ORCID: https://orcid.org/0000-0002-1278-6245; Connell, Carol A.; Gold, David; Chen, All-Shine; Sawyerr, Gosford; Shapiro, Andrea B.; Pope, Janet E. ORCID: https://orcid.org/0000-0003-1479-5302 und Schulze-Koops, Hendrik ORCID: https://orcid.org/0000-0002-1681-491X
(2022):
Infections in patients with rheumatoid arthritis receiving tofacitinib versus tumour necrosis factor inhibitors: results from the open-label, randomised controlled ORAL Surveillance trial.
In: Annals of the Rheumatic Diseases, Bd. 81, Nr. 11: S. 1491-1503
[PDF, 1MB]
Ramos-Casals, M.; Maria, A.; Suarez-Almazor, M. E.; Lambotte, O.; Fisher, B. A.; Hernandez-Molina, G.; Guilpain, P.; Pundole, X.; Flores-Chavez, A.; Baldini, C.; Bingham, C. O.; Brito-Zeron, P.; Gottenberg, J. -E.; Kostine, M.; Radstake, T. R. D.; Schaeverbeke, T.; Schulze-Koops, H.; Calabrese, L.; Khamashta, M. A.; Mariette, X.; Kostov, Belchin; Calabrese, Cassandra; Retamozo, Soledad; Ma Aguilar, Eva; Richter, Michael David; Lidar, Merav; Fisher, Ben; Michot, Jean Marie; Liew, David; Heiberg, Marte Schrumpf; Danda, Debashish; Olsson, Peter; Suzuki, Yasunori; Citera, Gustavo; Kawano, Mitsuhiro; Kilickap, Saadettin; Arrieta, Oscar; Moca Trevisani, Virginia Fernandes; Praprotnik, Sonja; Horvath, Ildiko Fanny und Azuma, Naoto
(2019):
Sicca/Sjogren's syndrome triggered by PD-1/PD-L1 checkpoint inhibitors. Data from the International ImmunoCancer Registry (ICIR).
In: Clinical and Experimental Rheumatology, Bd. 37, Nr. 3:
S114-S122